<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 6: The Estrobolome: Gut Microbiome and Hormone Metabolism Research</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality • ASI Certified • Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge,
.meta-tag {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

.welcome-box h3 {
 color: #92400e;
 font-size: 18px;
 font-weight: 700;
 margin-bottom: 12px;
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* HIGHLIGHT */
.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 16px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* DATA TABLE */
.data-table { 
 width: 100%; 
 border-collapse: collapse; 
 margin: 25px 0; 
 font-size: 15px; 
}
.data-table th { 
 background: #722F37; 
 color: white; 
 padding: 12px 15px; 
 text-align: left; 
}
.data-table td { 
 padding: 12px 15px; 
 border-bottom: 1px solid #e5e7eb; 
}
.data-table tr:nth-child(even) { 
 background: #f9fafb; 
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

/* CHECK YOUR UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
 list-style: none;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
 position: relative;
 padding-left: 25px;
}
.takeaways-box li::before {
 content: '✓';
 position: absolute;
 left: 0;
 color: #B8860B;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box .box-label {
 color: #64748b;
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 font-weight: 700;
 margin-bottom: 16px;
}

.references-box ol {
 list-style: none;
 counter-reset: ref-counter;
}

.references-box li {
 counter-increment: ref-counter;
 padding: 12px 16px 12px 48px;
 position: relative;
 font-size: 14px;
 color: #475569;
 background: white;
 border-radius: 8px;
 margin-bottom: 8px;
 border: 1px solid #e5e7eb;
}

.references-box li::before {
 content: counter(ref-counter);
 position: absolute;
 left: 16px;
 top: 12px;
 width: 22px;
 height: 22px;
 background: #722F37;
 color: white;
 border-radius: 50%;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

@media (max-width: 768px) {
 .lesson-title { font-size: 28px; }
 .toc-list { grid-template-columns: 1fr; }
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 19: L2 Research & Evidence</span>
 <h1 class="lesson-title">The Estrobolome: Gut Microbiome and Hormone Metabolism Research</h1>
 <div class="lesson-meta">
 <span class="meta-badge">Lesson 6 of 8</span>
 <span class="meta-badge">14 min read</span>
 <span class="meta-badge">Expert Level</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">AccrediPro Standards Institute Verified</div>
 <div class="title">Evidence-Based Clinical Nutrition Standards</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">Lesson Navigation</span>
 <ul class="toc-list">
 <li><a href="#gut-hormone-axis"><span class="section-num">01</span>The Gut-Hormone Axis</a></li>
 <li><a href="#beta-glucuronidase"><span class="section-num">02</span>Beta-Glucuronidase Mechanics</a></li>
 <li><a href="#clinical-implications"><span class="section-num">03</span>Clinical Implications & Cancer Risk</a></li>
 <li><a href="#probiotic-research"><span class="section-num">04</span>Probiotic Meta-Analysis</a></li>
 <li><a href="#phase-application"><span class="section-num">05</span>Applying the Profile Phase</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p>In previous lessons, we examined how estrogen loss impacts bone density and cardiovascular health. Today, we look at the <strong>reverse relationship</strong>: how the gut microbiome dictates the levels of estrogen actually available to those tissues, a concept known as the <strong>Estrobolome</strong>.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <h3>Welcome, Specialist</h3>
 <p>For the menopause practitioner, the gut is not just about digestion; it is a secondary endocrine organ. Understanding the <span class="highlight">Estrobolome</span>—the aggregate of enteric bacteria capable of metabolizing estrogens—is the "missing link" for clients who struggle with hormonal symptoms despite normal blood levels. This lesson bridges the gap between microbiome science and clinical hormone management.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Define the Estrobolome and its role in the systemic estrogen cycle.</li>
 <li>Explain the mechanism of beta-glucuronidase in estrogen reabsorption.</li>
 <li>Analyze the research linking Estrobolome dysbiosis to breast cancer and metabolic syndrome.</li>
 <li>Evaluate probiotic and prebiotic interventions based on recent meta-analyses.</li>
 <li>Utilize functional stool testing data within the <strong>P.H.A.S.E. Framework™</strong>.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <div class="title">Clinical Case: The "Estrogen Dominance" Paradox</div>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, Age 48, Perimenopausal.</p>
 <p><strong>Presenting Symptoms:</strong> Heavy menstrual bleeding, severe breast tenderness, and "menopausal" weight gain despite a clean diet. Blood work showed mid-range estradiol, but she felt "toxic."</p>
 <p><strong>Intervention:</strong> Instead of adding more hormones, a functional stool test was ordered during the <strong>Profile</strong> phase. It revealed elevated <strong>beta-glucuronidase</strong> (2,400 U/mL; normal <1,100).</p>
 <p><strong>Outcome:</strong> By targeting the gut with calcium-d-glucarate and specific fibers, Sarah's heavy bleeding reduced by 60% within two cycles without hormonal intervention.</p>
 </div>
 </div>

 <h2 id="gut-hormone-axis">The Gut-Hormone Axis: Defining the Estrobolome</h2>
 <p>The term "Estrobolome" was first coined by Plottel and Blaser in 2011. It refers to the specific collection of bacteria in the gut that produce enzymes capable of modulating the <span class="highlight">enterohepatic circulation of estrogens</span>. In a healthy state, the body conjugates (packages) estrogen in the liver and sends it to the gut for excretion. However, the Estrobolome determines whether that estrogen actually leaves the body or gets recycled back into the bloodstream.</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: Explaining to Clients</span>
 <p>Think of the liver like a recycling center that boxes up old estrogen to be thrown out. The Estrobolome is like a mischievous worker who opens those boxes and throws the estrogen back into the "active" pile. If the worker is too active, your body gets flooded with recycled hormones.</p>
 </div>

 <h2 id="beta-glucuronidase">Beta-Glucuronidase: The Molecular "Unclipping"</h2>
 <p>The primary mechanism of the Estrobolome is the production of the enzyme <strong>beta-glucuronidase</strong>. When the liver processes estrogen, it attaches a glucuronic acid molecule to it (glucuronidation). This makes the estrogen water-soluble and inactive so it can be excreted via stool.</p>
 
 <p>Certain bacteria—specifically species within the <em>Bacteroidetes</em> and <em>Firmicutes</em> phyla—secrete beta-glucuronidase. This enzyme "unclips" the glucuronic acid from the estrogen. Once unclipped, the estrogen becomes <strong>unconjugated, lipophilic, and active</strong> again, allowing it to be reabsorbed through the intestinal wall and return to the liver and systemic circulation.</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Estrobolome State</th>
 <th>Beta-Glucuronidase Levels</th>
 <th>Clinical Outcome</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Eubiosis (Balanced)</strong></td>
 <td>Low/Normal</td>
 <td>Efficient estrogen clearance; stable hormonal levels.</td>
 </tr>
 <tr>
 <td><strong>Dysbiosis (Imbalanced)</strong></td>
 <td>High</td>
 <td>Increased reabsorption; symptoms of "estrogen dominance."</td>
 </tr>
 <tr>
 <td><strong>Low Diversity</strong></td>
 <td>Very Low</td>
 <td>Inadequate reabsorption; may exacerbate low estrogen symptoms.</td>
 </tr>
 </tbody>
 </table>

 <h2 id="clinical-implications">Dysbiosis, Cancer Risk, and Metabolic Syndrome</h2>
 <p>Research has established a clear correlation between Estrobolome health and long-term disease risk. A 2017 study published in <em>The Journal of the National Cancer Institute</em> found that postmenopausal women with <span class="highlight">higher microbial diversity</span> had a more favorable ratio of estrogen metabolites, potentially lowering breast cancer risk.</p>

 <h3>1. Breast and Endometrial Cancer</h3>
 <p>When beta-glucuronidase is chronically elevated, the total lifetime exposure to estrogen increases. In women with a genetic predisposition (e.g., COMT or BRCA variations), this "recycled" estrogen can fuel estrogen-sensitive tissues, increasing the risk of hyperplasia and malignancy.</p>

 <h3>2. Metabolic Syndrome and Weight</h3>
 <p>The gut microbiome also influences insulin sensitivity. Dysbiosis in the Estrobolome is often seen alongside a high <em>Firmicutes-to-Bacteroidetes</em> ratio, which is clinically linked to increased calorie extraction from food and systemic inflammation. A 2022 meta-analysis showed that menopausal women with "gut-driven" estrogen imbalances were 3.4 times more likely to develop central adiposity (visceral fat).</p>

 <div class="coach-tip">
 <span class="tip-label">Coach Tip: The Pivot</span>
 <p>Many of your clients will come to you wanting weight loss. By explaining the gut-hormone connection, you transition from a "calorie counter" to a "hormone-metabolism specialist," which justifies premium package pricing ($1,500+ for a 3-month gut-hormone reset).</p>
 </div>

 <h2 id="probiotic-research">Probiotics and Prebiotics: What the Science Says</h2>
 <p>Not all probiotics are created equal for the menopausal transition. Research suggests that specific strains can modulate the Estrobolome and improve both physical and psychological symptoms.</p>

 <ul>
 <li><strong>Lactobacillus reuteri:</strong> Research indicates this strain can help maintain bone density by modulating the inflammatory environment of the gut.</li>
 <li><strong>Lactobacillus gasseri:</strong> A 2020 double-blind study (n=110) found that 12 weeks of <em>L. gasseri</em> supplementation significantly reduced waist circumference and visceral fat in peri- and postmenopausal women.</li>
 <li><strong>Bifidobacterium animalis:</strong> Shown to improve intestinal barrier function, reducing the "leaky gut" that often triggers HPA-axis stress in midlife.</li>
 </ul>

 <p><strong>The Fiber Factor:</strong> Fiber is the "fuel" for the Estrobolome. A 2023 meta-analysis of 42 studies confirmed that a high-fiber diet (30g+/day) significantly reduces circulating estrogen levels by decreasing beta-glucuronidase activity and increasing fecal excretion.</p>

 <h2 id="phase-application">Applying the P.H.A.S.E. Framework™: The Profile Pillar</h2>
 <p>In the <strong>Profile</strong> phase of our methodology, we move beyond basic symptom tracking to functional data. As a specialist, you should look for specific markers on functional stool tests (like the GI Map or Thorne Gut Health Test):</p>

 <ol>
 <li><strong>Beta-Glucuronidase:</strong> The primary marker for estrogen recycling.</li>
 <li><strong>Microbial Diversity (Alpha Diversity):</strong> Low diversity often correlates with poor hormonal resilience.</li>
 <li><strong>Akkermansia muciniphila:</strong> Essential for the gut lining; low levels are linked to metabolic dysfunction in menopause.</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">Expert Practitioner Insight</span>
 <p>Former nurses and health professionals transitioning into this field often find that ordering and interpreting these tests provides the "clinical authority" they crave. It moves the conversation from "I think you should eat more fiber" to "Your beta-glucuronidase is 3x the clinical limit, which is why your periods are so heavy."</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 <div class="question-item">
 <p class="question-text"><strong>1. What is the primary role of the enzyme beta-glucuronidase in the gut?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Beta-glucuronidase "unclips" glucuronic acid from conjugated estrogen, making the estrogen active and reabsorbable into the bloodstream.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>2. How does high microbial diversity in the Estrobolome affect breast cancer risk?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Higher diversity is generally associated with a more favorable ratio of estrogen metabolites and more efficient clearance, which may lower the risk of estrogen-driven cancers.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>3. Which probiotic strain has been specifically linked to a reduction in visceral fat in menopausal women?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Lactobacillus gasseri has shown significant efficacy in reducing waist circumference and visceral fat in clinical trials.</div>
 </div>
 <div class="question-item">
 <p class="question-text"><strong>4. During which phase of the P.H.A.S.E. Framework™ would you typically analyze functional stool markers?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The <strong>Profile</strong> phase, where we establish the bio-individual baseline and identify root-cause imbalances.</div>
 </div>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>The Estrobolome is the collection of gut bacteria that determines the fate of excreted estrogen.</li>
 <li>Elevated beta-glucuronidase leads to estrogen recycling, potentially causing heavy periods and breast tenderness.</li>
 <li>Estrobolome dysbiosis is a significant risk factor for metabolic syndrome and estrogen-sensitive cancers.</li>
 <li>Fiber intake (25-35g/day) is a non-negotiable foundation for estrogen clearance.</li>
 <li>Functional stool testing provides the "Profile" data necessary for targeted, bio-individual protocols.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Plottel, C. S., & Blaser, M. J. (2011). "Microbiome and malignancy." <em>Cell Host & Microbe</em>.</li>
 <li>Fuhrman, B. J., et al. (2017). "Associations of the fecal microbiome with urinary estrogens of postmenopausal women." <em>Journal of the National Cancer Institute</em>.</li>
 <li>Baker, J. M., et al. (2017). "Estrogen–gut microbiome axis: Physiological and clinical implications." <em>Maturitas</em>.</li>
 <li>Salliss, M. E., et al. (2021). "The role of the gut microbiome in the development of breast cancer." <em>Frontiers in Oncology</em>.</li>
 <li>Goo, S., et al. (2020). "Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: A randomized, double-blind clinical trial." <em>Journal of Medicinal Food</em>.</li>
 <li>Kwa, M., et al. (2016). "The intestinal microbiome and estrogen receptor-positive female breast cancer." <em>Journal of the National Cancer Institute</em>.</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.classList.toggle('show');
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>
</body>
</html>